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Cytotoxic and Mutagenic Effects of Specific
Carcinogen-DNA Adducts in Diploid
Human Fibroblasts
by J. Justin McCormick* and Veronica M. Maher*
A comparison of the cytotoxicity and mutagenicity of a series of carcinogens in normal diploid human
fibroblasts and in cells deficient in one or more DNA repair processes has provided insight into the specific
DNAadduct(s) responsible forthesebiological effects. Thecarcinogenstested include ultravioletradiation;
reactive derivatives of structurally related aromatic amides; metabolites of benzo(a)pyrene; the simple
alkylating agents N-methyl-N'-nitro-N-nitrosoguanidine and N-ethyl-N-nitrosourea; and aflatoxin B1 di-
chloride, a model for the reactive 2,3-epoxide of aflatoxin B1. Exponentially growing cells were exposed
to agents and assayed for mutations (induction of6-thioguanine resistance) and cell killing (loss ofcolony-
forming ability). Cells deficient in repair of particular DNA adducts or lesions proved more sensitive to
the agent causing those lesions than did normally repairing cells. Many ofthe carcinogens were compared
for their mutagenic and/or cytotoxic effect, not only as a function of dose administered, but also as a
function ofthe initial number ofadducts or photoproducts induced in DNA and the number remaining at
critical times posttreatment. Density-inhibited cultures were exposed to cytotoxic and mutagenic doses.
Immediately after treatment, or after various lengths of time in confluence, the cells were harvested and
analyzed for the number oflesions remaining in DNA. A portion was plated at lower densities and assayed
for mutations and/or for survival. In several instances, the adducts were analyzed by high-pressure liquid
chromatography. As an alternative approach, cells were synchronized and treated at various times prior
to the onset of DNA synthesis and analyzed for survival and/or the frequency of mutations. The results
demonstrated a high correlation between the number of DNA lesions remaining unexcised at the time the
DNA was replicated and the frequency ofmutations induced. Comparative studies ofthe frequency ofUV-
induced transformation (to anchorage independence) ofnormal and repair-deficient cells showed this also
to be true for transformation.
Introduction
A central question under investigation in many lab-
oratories concerns thebiological effects ofDNA adducts
and photoproducts induced in cells by exposure to en-
vironmental mutagens and carcinogens. As part of on-
going studies of the mechanisms of carcinogenesis, we
and our co-workers have investigated the cytotoxicity,
mutagenicity, and transforming activity of a number of
chemical carcinogens and radiation in diploid human fi-
broblasts in culture. In particular, we have made use
of human cells which differ in their ability to excise or
remove such lesions from their DNA to determine the
answer to the following. Is cell killing correlated with
the initial number of DNA adducts or the number of
remaining at a particular time posttreatment? Are po-
tentially mutagenic lesions converted into mutations
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during excision repair? What is the role of semiconser-
vative DNA replication in mutation induction? Are par-
ticular lesions or adducts intrinsically more mutagenic
or more cytotoxic than others? Are genetic changes re-
sulting from unrepaired DNA lesions causally involved
in the process of neoplastic transformation?
To address these questions, we developed quantita-
tive assays formeasuringthe cytotoxic, mutagenic, and
oncogenic effect of carcinogens in diploid human skin
fibroblastsderived fromneonatalforeskinorskinbiopsy
material (1-8). The use ofhuman cells offers a number
ofadvantages. They grow well in culture and clone with
40 to 80% efficiency. They can be treated with direct-
acting mutagens, and the cytotoxic effect quantitated
from the decrease in their cloning ability. Compounds
requiring activation can also be used if the cells are
provided with a source of activation, such as metabo-
lizing feeder cells (9,10). The dose-dependent induction
of mutations by carcinogens can be quantitated by de-
termining the frequency of cells able to grow in theMcCORMICK AND MAHER
presence of the base analogs 8-azaguanine or 6-thio-
guanine (TG) as a result of inactivation of a functional
hypoxanthine(guanine)phosphoribosyltransferase
(HPRT) (2,11). Another genetic marker we have used
to measure mutation induction is resistance to diphth-
eria toxin (DT) which results from inactivation of its
receptor site on the elongation factor 2 used in protein
synthesis (12). The frequency oftransformation ofnor-
mal human cells can be measured by determining the
frequencyofcellsabletoexhibitanchorage-independent
growth, i.e., colony formation in semisolid medium con-
taining 0.33% agar (5,8,). We and others have shown
that human cells isolated from anchorage-independent
colonies can produce nodular growths when propagated
and injected into X-irradiated athymic mice, whereas
cells that do not express this phenotype do not grow in
these animals (5,8,13,14).
Although strains of human fibroblasts in culture do
not have an infinite life span (15), the number of cells
one can obtain from a single fibroblast population is so
large (16)thatitprovidesenoughcellsformanyworkers
for several years. The advantage ofusing these human
fibroblast cell lines over the commonly used rodent cell
lines with infinite life spans is that the former retain
theirdiploid karotype throughout their life span, whereas
the latter usually are aneuploid (17) and therefore no
longer faithfully represent the normal cells of the spe-
cies from which they were obtained.
Another advantage ofworking with strains ofdiploid
human fibroblasts is that they retain the excision repair
capability present in the individual from which they
were obtained, whereas cell lines, especially those of
rodent origin, often lose their characteristic excision
repair capabilities with time in culture (18). Most im-
portantly, human fibroblast cell strains deficient in rate
ofDNA repair are available, e.g., from xeroderma pig-
mentosum (XP) patients (19) orothersources (20). Cells
from the majority of XP patients have a reduced rate
ofexcision ofpyrimidine dimers (21) or adducts formed
bythecovalentlinkage ofbulkyringstructurestoDNA,
such asthoseformedbyreactive derivatives ofaromatic
amides (1,22,23), polycyclic aromatic hydrocarbons
(11,24,25), oraflatoxins (26,27). Theyarenormalintheir
ability to repair lesions induced by methylating agents,
such as MNNG (28). Recently, humancelllines deficient
in 06-methylguanine-DNA-methyltransferase (MT) ac-
tivity have been identified (20). These repair-deficient
lines are very useful for determining the biological sig-
nificance of06-methylguanine compared to all the other
methyl adducts induced by MNNG.
Studies with UV Radiation
Excision Repair Reduces Cytotoxicity and
Mutagenicity
The results of our comparative studies with normal
and excision repair-deficient XP cells show that the de-
gree of cell killing and the frequency of induction of
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FIGURE 1. Cytotoxicity, mutagenicity, and transforming ability of
UV radiation in human cells: (0, O, 0) normal cells; (A, A, A)
XP2BE cells; (v, V) XP7BE cells; (solid symbols) populations ir-
radiated in exponential growth; (open symbols) cells synchronized
by release from confluence and irradiated shortly before onset of
S phase; (half-ffiled symbols) cells irradiated 18 to 20 hr prior to
S. See text for details.
mutations to TG resistance is correlated with the cells'
rate ofexcision ofpyrimidine dimers. For example, when
four cell lines, each with a cell cycle of approximately
the same length but with different rates of excision of
UV-induced DNA damage, were irradiated in exponen-
tial growth and assayed for survival and induction of
mutations, normal cells with rapid excision were much
more resistant to the potentially lethal and mutagenic
effect of UV than any ofthe three XP strains. The XP
cell line (XP12BE) with the lowest rate of nucleotide
excision repair capability (29) was the most sensitive of
all; those with a repair rate 16 to 20% that of normal
(XP2BE, XP7BE) showedsurvivalandmutation curves
slightly more resistant than XP12BE (2,5). The nor-
mally excising human cells were the most resistant.
They exhibited 100% survival and no measurable in-
crease in mutant frequency at low doses of UV, doses
that were extremely effective for the XP cells. Only
when exposed to much higher doses ofUV did the nor-
mal cells show a response (see Fig. 1).
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Since the essential difference among these strains is
their respective rates of excision repair of UV-induced
damage, the data are consistent with the hypothesis
that there is a certain amount oftime available for ex-
cision repairbetween the UV irradiation and the events
responsible for cell killing and mutation induction. The
faster a cell can remove the potentially lethal and/or
mutagenic damage from DNA, the lower the degree of
cellkillingandfrequency ofmutants. We suggestedthat
the cellular event involved is semiconservative DNA
synthesis on a damaged template (2).
Lengthening Time between Exposure and
Onset of S-Phase Decreases the Biological
Effects of UV
If mutations result directly or indirectly from DNA
replication on a template containing unexcised lesions,
then if one were to extend the time between the intro-
duction of the lesions and the onset of DNA synthesis,
it should be possible for a cell that has at least some
capacity for excision repair to remove those lesions be-
fore they can cause mutations. Similarly, if cell killing
reflects replication on a damaged template, then ex-
tending the time available for excision repair before
allowing cells to replicate their DNA should result in
increased survival. Thishypothesis wastested bygrow-
ing cells to confluence to achieve density inhibition of
cell replication, irradiating them, and allowing them
various lengths oftime to remove potentially cytotoxic
or mutagenic DNA lesions. After reaching confluence,
cells were refed once and then held for 72 hr without
refeeding. Autoradiography studies in cells maintained
in the resting state under our conditions demonstrated
that < 0.5% ofthe cellsincorporated tritiatedthymidine
during an 8-hr labeling period (2). However, such cells
are capable of excision repair (22,24,30).
We irradiated confluent normal cells with a large
enough dose ofUV radiation to cause cell killing and to
induce mutations in exponentially growing populations,
i.e., 5 to 10 J/m2, and held them in the nonreplicating
state for 7 days. XP12BE cells were given 0.5 J/m2.
When the cells were trypsinized and plated at lower
densities to assay survival and induction of mutations,
the normal population showed no cell killing and no mu-
tation induction. In contrast, XP12BE cells irradiated
at confluence exhibited the same degree of cell killing
and mutation induction as found in cycling cells (2).
To determine how much time it takes for human cells
to remove potentially cytotoxic and/or mutagenic le-
sions induced by UV, we irradiated a series ofconfluent
cultures and released one immediately and the others
at various times following radiation. There was a grad-
ual decrease in the lethal and mutagenic effects of the
radiation. After 15 hrin the Go state, cultures ofnormal
cells irradiated with 7 J/m2, which initially exhibited a
survival of 20% and an induced mutation frequency of
50 x 106, exhibited 100% survival and a frequency of
mutations near background. XP5BE cells, with a much
slower rate of excision (19), were irradiated with only
1 J/m2, so as to obtain an initial survival of -20%. With
a 7-fold lower number of lesions to excise, these cells
also showed a gradual increase in survival with time
held in confluence. A period of24 hr in the Go state was
sufficient for both sets of cells to remove a sufficient
numberoflesions sothatwhentheywerereleased, they
exhibited -100% survival (2).
Shortening Time between Exposure to
DNA-Damaging Agents and Onset of S-
Phase Increases the Mutagenic Effect
To see ifsemiconservative DNA replication ofa dam-
aged template were the cellular event responsible for
cell killing and/or mutation induction, we synchronized
cells by release from confluence (Go state). Autoradiog-
raphy indicated that after 72 hr in a mitogen-depleted
density-inhibited state, human cells plated at - 5 x 103
cells/cm2 in fresh medium containing 15% fetal bovine
serumbeginsemiconservative DNAsynthesis(S-phase)
after -24 hr (31). Normal cells and XP12BE cells were
irradiated under conditions that allowed 24,18, or 1 hr
to occur between irradiation and the scheduled begin-
ningofS-phase. (Thecellsthatweretohave24hrbefore
S were irradiated in confluence and then replated at
lower densities. The cells that were to be irradiated 18
hr before S, or just before S, were released from con-
fluence so as to have the appropriate number of hours
prior to irradiation in situ at the lower densities.) The
results are shown in Figure 2.
Repair-proficient normal cells irradiated shortly be-
fore S exhibited the highestfrequencyofmutants; those
irradiated 18 to 24 hr prior to S gave a much lower
frequency. XP cells showed no significant difference in
mutation frequency whether irradiated in Go and re-
leased, or in early G1, or just prior to S, as predicted
from their virtual lack ofexcision repair. These results
indicate that in cells capable of removing lesions, the
time available for excision repair between irradiation
and S is, indeed, the determining factor for mutagen-
icity. Ifthe increased mutation frequency exhibited by
cells irradiated just prior to S merely reflected differ-
ences in the physical state of DNA in these cells com-
pared with that of cells in early G1, so that a larger
number of lesions were induced or lesions located in
more critical sites, the XP cells would also have shown
this difference.
An unexpected finding in this study was that cell kill-
ingdid notshow significantcellcycle dependence. When
allowance is made for the shielding effect on the con-
fluent cells and their need to be plated afterirradiation,
there is no significant difference in the slope ofthe sur-
vival curve ofcells irradiated at the onset of S or 18 or
24 hr prior to S-phase (31). Yet the normally excising
cells were capable ofsurviving 10-fold higherdosesthan
XP12BE cells, indicating that excision repair postir-
radiation is involved in eliminating potentially lethal
effects ofUV. Based on these results and those ofKan-
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FIGURE 2. Cytotoxicity and mutagenicity of UV in (A, *, V, *)
NF cells or (A, 0, V, O) XP12 BE cellsirradiated underconditions
designed to allow various lengths of time for excision repair to
take place prior to the onset of S phase. Cells irradiated in con-
fluence (Go) and then released and plated at lower densities (U,
O); cells released from Go and irradiated 6 hr later (V, V); cells
released and irradiated 24 hr later (0, 0) cells replated from
asynchronously growing cultures and irradiated 16 hr later (A, A).
From Konze-Thomas et al. (31) with permission.
tor et al. (32) and Hildebrand and Strniste (33), we
suggested that the amount oftime available for excision
before cell death is regulated by the cells' need for crit-
ical cellular protein and their respective mRNAs. Ifthe
DNAtemplate fortranscription ofthese mRNAs is still
blocked by lesions at the time the cell has need ofthem,
reproductive death (i.e., inability to form a colony) is
the result. Although the kinds of proteins being syn-
thesized by cells in early G1 differ from thosejust prior
to S, the overall average need for transcription and
translation by the two populations may well be com-
parable. If so, this could explain why the lethal effect
of low doses of UV was comparable in the two
populations.
The hypothesis that the cells' need for some critical
proteins at some point subsequent to irradiation is re-
sponsible for cell death could also explain why resting
cells irradiated in confluence (Go) and then held for 8 or
16 hr before being allowed to cycle showed a higher
survival than cells released immediately (2). Go cells
have a lower metabolic state than cells in exponential
growth, and if following irradiation, fewer critical pro-
teins are needed immediately than are needed by cells
released and allowed to begin the cell cycle, these cells
would have time to remove the blocking DNA damage.
This conclusion is consistent with the fact that XP12BE
cells, which do not remove such lesions, show no dose-
modifying effect when held in the Go state (2).
Transformation of Human Cells: Its
Relationship to DNA Lesions
To see ifthe numberofUV-induced lesions remaining
unexcised correlates with induction of anchorage inde-
pendence, a phenotype characteristic of tumorigenic
cells, we compared irradiated normalcells, XP7BE cells
and XP12BE cells forthe frequency ofcells able to grow
in soft agar. The results are included in Figure 1 (bot-
tom). Note that these XP cells are not malignant; the
biopsies from which they are derived are always ob-
tained from nonsunlight-exposed areas of skin.
The data in Figure 1 indicate that to achieve a par-
ticular degree of cell killing, mutagenesis, and trans-
formation, normal cells have to be exposed to 8- to 10-
fold higher doses of UV radiation than XP cells. As
discussed above, this is the result expected ifinduction
of anchorage independence, as well as TG resistance,
results ultimately from DNA damage remaining unex-
cised in the cell at some critical time after irradiation
and if, because ofthe difference intheirrespectiverates
of excision repair, the average number of lesions re-
maining at this critical time is approximately equal to
the three populations.
The open symbols in Figure 1 represent data from
cells irradiated shortly after the onset of S-phase; the
half-open symbols arefor cellstreated in earlyG1 phase.
The frequency oftransformants (as well as mutants) in
the normal population was much loweriftime was avail-
able for excision repair prior to S-phase. As expected,
this was not true of the XP12BE population. The fact
that allowing substantial time for excision before DNA
synthesis eliminated the potentially mutagenic and
transforming effect ofUV radiation in normal cells, but
not in XP12BE cells. suggests that DNA synthesis on
atemplate stillcontainingunexcisedlesionisthecellular
event responsible for "fixing" the mutations and trans-
formation. This is consistent with the findings by Ka-
kunaga (34). He showed that when confluent cultures of
a mouse cell line were exposed to 4-nitroquinoline-1-
oxide and then allowed to carry out excision repair but
not to replicate, the potential for focus formation was
gradually eliminated. However, when the cells were
allowed to undergo a single population doubling after
treatment before attaining confluence, additional time
in confluence did not decrease the transformation
frequency.
The similarity ofthe dose response for the two phen-
otypes in Figure 1 supports the idea that acquisition of
anchorage independence (transformation) in human cells
occurs as the result of a single mutational event. The
frequencies of mutants and transformants induced by
UV differ by a factor of -2.5. In our earliest experi-
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ments, using propane sultone, the difference was -22-
fold (8). However, a ratio of 2.5 is much closer to the
ratios we now routinely observe with a number ofagents.
The higher value reported in the early experiments can
beattributed inparttothe use ofadifferent lot ofserum
and a different type ofagar. Small technical differences
in the way the cells were handled may also have con-
tributed to the difference.
When cells derived from such agar colonies are iso-
lated, propagated and assayed forabilitytoformtumors
upon injection subcutaneously into sublethally X-irra-
diated athymic mice, nodules sometimes arise at the
site of injection within a few weeks. These attain a
maximum size of 7 to 10 mm in diameter and then stop
growingandregress. Fullymalignant cellsderived from
fibrosarcomas produce nonregressing tumors. There-
fore, we suggest that acquisition of anchorage inde-
pendence is one of the steps in the transformation of
normal human fibroblasts and that cells with this prop-
erty are partially transformed (35).
Studies with Aromatic
Amide Derivatives
These same approaches were used to determine if
DNA adducts were responsible forthe cytotoxic or mu-
tagenic effect of selected chemical carcinogens. The
chemicals selected were those we showed cause greater
cell killing and induction of mutations in XP cells than
in normal cells. Examples are the reactive derivatives
ofaromatic amide carcinogens, i.e., N-acetoxy-4-acetyl-
aminobiphenyl(N-AcO-AABP),N-acetoxy-2-acetylamino-
fluorene (N-AcO-AAF), N-acetoxy-2-acetylamino-
N-AcO-AAPh N-AcO-AAF
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phenanthrene (N-AcO-AAP), and N-acetoxy-4-acetyl-
aminostilbene (N-AcO-AAS) (1,22,23).
Confluent cultures ofnormal and XP12BE cells were
exposed to these four carcinogens at concentrations ad-
justed to result in 20% survival. One set of cells was
released immediately and assayed for survival and for
the number of residues bound to the DNA. The other
sets were held for 18, 36, 72, or 144 hr before being
released and assayed for the number of residues re-
maining in the DNA and for survival. The results (Fig.
3) showed that the rate ofrecovery was directly related
to the rate ofremoval ofthe bound carcinogen residues
from DNA. In the XP12BE cells, there was little or no
removal of the bound material and no evidence of re-
covery from the potentially lethal effects of the initial
exposure, even over a period of 6 days (22).
These results indicate that cell killing (loss of repro-
ductive capacity) is directly related to the presence of
unexcised adducts. They suggest that all the DNA ad-
ducts formed by a particular agent contribute to its
cytotoxic effect. If only one of several adducts were
cytotoxic, the rate of loss ofthat one would have to be
proportional to the rate of loss of the total number of
adducts to give the results seen in Figure 3.
Unpublished studies by Maher and McCormick com-
paring the mutagenic effect of N-AcO-AAF, N-AcO-
AABP, and N-AcO-AAS indicate that the frequency of
TG resistent mutants induced in normal cells per lethal
effect (e.g., 37% survival dose) is equal. From Figure
3 it will be seen that a 37% survival dose corresponds
to ca. 50 initial adducts per 106 nucleotides for N-AcO-
AAF and N-AcO-AABP, but only ca. 4 adducts per 106
nucleotides for N-AcO-AAS. Additional studies with
synchronized normal human cells and excision-minus
6
N-AcO-AABP
0 3 6
DAYS IN CONFLUENCE POST CARCINOGEN TREATMENT
FIGURE 3. Comparison of the rate of recovery from the potentially cytotoxic effects of four aromatic amide derivatives with the rate of
removal of radioactively labeled DNA adducts: (A, 0, U, *) normal cells; (A, 0, O, O) XP12BE cells. Cells were treated at confluence
and assayed for survival after the designated period oftime at confluence. From Maher et al. (23) with permission.
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XP12BE cells are in progress to determine ifunexcised
N-AcO-AAS adducts are intrinsically more cytotoxic
and mutagenic than those formed by the related deriv-
atives, or ifthis observation reflects the slower rate of
repair ofthe N-AcO-AAS-induced adducts.
Studies with Benzo(a)pyrene-
7,8-diol-9,1O-epoxide
Weusedthe sameapproach toinvestigate thekinetics
ofremovalofDNAadductsformedbyradioactive 7,B,8cx-
dihydroxy-9a,lOa-epoxy-7,8,9, 10-tetrahydrobenzo(a)-
pyrene (anti-BPDE) and the rate of recovery of human
cells from its potentially cytotoxic and mutagenic ef-
fects. Large populations ofdensity-inhibited cells were
treated, and a fraction of them were harvested imme-
diately and assayed for DNA adducts, survival, and
mutation induction. The rest were assayed after 2, 4,
or 8 days in confluence (24). The results (Fig. 4) showed
that residues were initially removed rapidly by the nor-
mal cells, but that after 4 days excision repair slowed
considerably. Similarly, the survival of the population
increased during that same period, and the frequency
ofmutants decreased almost to background. These data
indicate that the potentially cytotoxic and mutagenic
lesions were removed with about the same kinetics as
were the total number of DNA adducts (24).
The HPLC characterization of the DNA adducts in-
dicated that the major adduct was the N2-guanyl deriv-
ative (36). Finer resolution by HPLC ofthese adducts,
carried out by Tejwani et al. (37), indicates that at least
80% of the radioactivity is accounted for by two N2
deoxyguanosine adducts 7a-BPDE and 73-BPDE. The
kinetics of decrease oftritium label in our combined N2
deoxyguanosine peak corresponded to the kinetics of
decrease of radioactivity in the total DNA with time
and also with the kinetics of recovery from the muta-
tions and the cytotoxicity. If unstable adducts whose
existence could not be noted, or minor adduct(s) that
were not observed because of the limits of sensitivity
of the assays are responsible for the mutagenic and/or
cytotoxic effects of the anti-BPDE, they must be ex-
cised with the same kinetics as the N2-guanyl deriva-
tives to account for these results (24).
The cytotoxic and mutagenic response manifested by
normal cells on release from confluence are directly re-
lated to the number of lesions in the DNA at the time
the cells are plated to lower densities, regardless of
whether the DNA contained this number oflesions be-
cause the cells had just been treated with anti-BPDE
or because they had received a much higher dose orig-
inally and had removed some of the original adducts
during the time they were held in confluence. These
resultsindicate that RNAandproteinlesions contribute
only indirectly to the cytotoxic effects of such agents.
Further evidence for this is shown in Figure 5. Here,
the cells were exposed to 0.15, 0.2, 0.25, or 0.4 ,uM
tritiated anti-BPDE and assayed immediately for sur-
vival and number of adducts per 106 DNA nucleotides.
The results, identified in Figure 5 with the numeral 0,
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FIGURE 4. Kinetics ofremoval ofcovalently bound adducts (B) and
recovery of normal cells (circles) from the potentially cytotoxic
(A) or mutagenic (C) effects ofanti-BPDE. The cells were treated
in confluence, released on the designated days, and assayed for
survival of colony-forming ability, for the number of residues
bound to DNA, and after a suitable expression period, for the
frequency of induced mutations to thioguanine resistance. From
Yang et al (24) with permission.
show that initial binding levels of 6.5, 10.2, 14.7, and
16.3 residues per 106 nucleotides result in survivals of
40%, 27%, 16%, and 12%, respectively.
When the data from Figure 4, derived from cells
treated and then held in confluence, were analyzed in
the same manner and replotted with these data, the
points fell on the identical line. The survival they ex-
hibited when released from confluence was the same as
that obtained with cells exposed initially to a concen-
tration giving that number of residues per 106 nucleo-
tides and assayed immediately. Thus, the protein binding
and RNA binding that occurs with all such agents as a
result of the original treatment did not contribute sig-
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FIGURE 5. Cytotoxicity (A) and induced mutation frequency (B) as
functions of the number of BPDE-induced DNA adducts present
at the time cells were released from confluence and plated for
survival or for the beginning of expression of thioguanine resist-
ance: (@, O, e) normal cells; (A) XP12BE cells. The number of
days cells were held in confluence before being analyzed is indi-
cated next to each data point. The data represented by (0, 0,
and A) have been replotted from the data given in Fig. 4. From
Yang et al. (24) with permission.
nificantly to the ultimate level of cell killing. Similar
conclusions can be extrapolated for mutation induction.
Additional evidence that cell killing does not reflect
initial protein binding is the abnormal sensitivity ofXP
cells. We suggestthatcellkillingandmutationinduction
seen when cells are plated at lower densities reflect
DNAlesionsremainingunexcised inthe cells atthetime
of critical events in the replicating state.
Studies by Yang et al. (25) in our laboratory with
synchronized populations of normal and XP12BE cells
and more recently with XP4BE by Watanabe et al (38)
gave results similar to those shown in Figure 2 for UV
irradiated cells. The frequency of mutants in excision
repair proficient cells is highest in cells treated with
BPDE just at the beginning of S phase. Survival ex-
hibits only a very minor cell cycle-dependence when
concentrations ofagents areused thatdo notgive killing
below the 10% level.
Studies with an Aflatoxin B.
Derivative
Because aflatoxin B1 (AFB1) is known to be a potent
liver carcinogen at comparatively low doses, we wanted
to investigate its biological effects in human fibroblasts
as a function ofconcentration applied and initial number
of DNA adducts. However, this carcinogen requires
metabolic activation. Therefore, in our study (27) we
substituted aflatoxinB,-dichloride (AFB,-Cl2), a direct-
acting carcinogen which is a model for the proposed
ultimate reactive metabolite of AFB1 (the 2,3-epoxide)
(39).
Figure 6 compares the cytotoxic and mutagenic ef-
fects ofAFB1-C12 as a function ofthe concentration ad-
ministered. The slope of the survival curve for the
XP12BE cells is 3-fold steeper than that of the normal
cells; the slope ofthe induced mutation frequency curve
for the XP cells is 7-fold steeper. Such differences in
sensitivity might reflect differences in the amount of
reactive compound entering the cells or reaching the
DNA. However, thisis not true forAFB1-C12. Wefound
the same a linear relationship between the number of
DNA adducts in either strain of cells as a function of
the concentration administered. Comparison ofthe sur-
vivalofthetwostrains as afunctionoftheinitialnumber
of DNA adducts also showed the normal cells to be
significantly more resistant than XP12BE cells when
compared on the basis ofequal amounts of DNA bound
AFB1-C12 residues. These results suggest that the nor-
mal cells are more capable than XP cells of removing
potentially lethal and mutagenic lesions formed by this
agent before they can exert their biological effect (27).
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We compared the rate of loss of AFB1-Cl2-DNA ad-
ducts from cells treated and held in the nondividing
state (confluent) over several days, as well as their abil-
ity to recover from the potentially mutagenic and/or
cytotoxic effect of the agent. AFB1-C12 residues were
lost fromboth strains ofcells and both exhibited a grad-
ual increase in survival. However, the rate of loss of
adducts from the DNA in the normal cells was more
rapid than in XP cells and they exhibited recovery from
higher doses of AFB1-CI2 than XP cells (27).
Figure 7 shows the cytotoxicity obtained in normal cells
treated in confluence and released after various periods
oftime as afunction ofthenumberofAFB1-Cl2 residues
remaining in their DNA at the time of harvest. The
linear relationship obtained indicates that, at least at
theconcentrations ofAFB1-Cl2usedin ourexperiments,
cell killing by AFB1-Cl2 was directly related to the
amount ofunexcised DNAdamageremaininginthecells
at any time. The percent survival of normal cells con-
taining2 residues per 107nucleotides was -75%, whether
this was the amount originally bound after a low dose,
or the amount remaining after 2 days following a me-
dium dose or after 8 days following a higher dose.
HPLC studies indicated thatthemajorprimary DNA
adduct formed in the human cell and in isolated DNA
was the chemically unstable guanine derivative which
could undergo a change in structure with time post-
treatment to form a more stable secondary adduct (27).
The cytotoxic effect ofAFB1-CI2 was highly correlated
with the presence of either of these guanine adducts.
Evidence suggests that the primary adduct is an N7-
guanine adduct. The kinetics ofthe loss ofthis guanine
and its transformation into the more stable secondary
adduct resembled that reported recently (26) for the
major primary DNA adduct formed by the reaction of
AFB1 at the N-7 position of guanine in the DNA of
normal and XP cells and its transformation into the
putative AFB1-ring opened triamino pyrimidyl struc-
ture (40).
Acriticalquestion is whether one orthe other ofthese
two major adducts is responsible for the biological ef-
fects ofAFB1-C12. The fact that the survival of the XP
cells increased with time as the cells were held in con-
fluence indicates that the unstable adduct was poten-
tially cytotoxic. However, our data indicate that the
stable adduct formed from the initial adduct is equally
cytotoxic. This is because the level of cell killing per
adduct remaining in the cells did not differ with time
held intheGostate (Fig. 7), yetthe nature ofthe adduct
in the cellular DNA could be expected to change during
that period. Wang and Cerutti (41) reached this same
conclusion with the AFB1 in 10T'/2 mouse embryo cells
held in confluence.
BecausethefrequencyofmutationsindcuedbyAFBl-
Cl2 perlethal event is relatively low, we could not apply
the same technique to determine ifone or both adducts
are mutagenic. But the evidence shows that excision
repairbynormalcellsreducesthe potentiallymutagenic
effect. It may, however, do so by removingthe primary
lesions which would have been converted into a muta-
genic secondary form. Our data emphasize that loss of
AFB1-C12 adduct posttreatment protects cells from po-
tential mutations, i.e., repair is not responsible for the
mutations.
Studies with a Methylating Agent,
MNNG
Recently, Domoradzki et al. (20) investigated the bi-
ological significance ofanother type ofDNA repair sys-
tem, i.e., 06-methylguanine-DNA-methyltransferase
(MT), an acceptor protein that specifically removes
methyl groups from the O6 position of guanine in al-
kylated DNA (42). Three human cell lines were iden-
tified as being extremely deficient in this
methyltransferase activity. One is an XP cell line
(XP12RO) transformed to anindefinite life spanby Sim-
ian virus 40 (SV40); one GM3314 is a fibroblast cell line
from a skin biopsy of a patient with an inherited pre-
disposition to colon cancer (Gardner's syndrome) and
one, GM0011, is a skin fibroblast cell line from an ap-
parently normal fetus. A fourth cell line obtained by SV
40 virus transformation of normal fibroblasts (GM637),
exhibited anintermediatelevelofmethyltransferase ac-
tivity. The method ofPegg et al. (43) was used to mea-
sure the MT activity. This method uses HPLC to
determine the number of 06-methylguanine bases re-
maininginaDNAsubstrate afterexposuretoparticular
amounts of protein in the cell extract.
These repair-deficient cells and a series of cell lines
with normal levels ofMT were compared for sensitivity
to the killing and mutagenic effect of MNNG. Figure 8
(top) shows that three repair-deficient cell lines were
extremely sensitive to the cytotoxic action of MNNG
compared to cells with a normal ability to remove this
lesion and that the response of the GM637 cells was
intermediate. These data suggest that 06-methylguan-
ine is a potentially cytotoxic lesion in human fibroblasts
and that this repair system protects the cells. The data
in Figure 5 (bottom) show that mutations were induced
by low doses of MNNG in the three cell lines that lack
theabilitytoremovemethylgroupsfromthe06-position
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Of guanine. There was no significant increase in the
frequency of mutants in the methyl repair-proficient
cells at these low doses. Only at much higher concen-
trations did induction of mutations occur. The GM637
cells gave an intermediate response to mutation
induction.
Taken together, the biochemical and the biological data
indicate that 06-methylguanine, or any other lesion that
the MT can remove from methylated DNA, is the lesion
responsible for mutation induction by MNNG in human
cells. They also indicate that lack of MT activity is not
necessarly acharacteristic ofskinfibroblasts ofpersons
with a predisposition to colon cancer. This is because
included in the series of normal cells shown in Figure
5 are cell lines derived from several patients with Gard-
ner's syndrome (GM3948, 2938, 2974) and one with fam-
ilial polyposis coli (GM2355). Unlike GM3314, these cell
lines had a normal level of MT activity and a normal
response to MNNG (20).
Conclusion
In summary, our studies indicate that excision repair
in diploid human fibroblasts is essentially an error-free
process and that the ability to excise potentially cyto-
toxic and potentially mutagenic or transforming lesions
induced in DNA by UV radiation or by several classes
ofchemical carcinogens determines their ultimate biol-
ogic consequences. Other classes of carcinogens that
form "bulky" lesions in DNA can be expected to give
similar results. Adducts produced by methylating agents
are repaired by a completely different set ofrepair pro-
cesses. The data summarized here suggest that there
is a certain amount oftime available between the initial
exposureandthe onsetofthecellulareventsresponsible
for mutation induction, for cell transformation, and for
cell killing and that the critical event for the mutation
and transformation is DNA synthesis on a damaged
template. In contrast, the cytotoxicity studies indicate
that although a population's survival is determined by
the extentofexcisionrepairofpotentiallylethaldamage
from DNA before some critical cellular event(s), there
is no single cell-cycle-related event such as DNA syn-
thesis on a damaged template that determines
cytotoxicity.
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